Posted in | News | Gold | Uranium

Argus Contracts AK Drilling to Initiate Kaituma Uranium/Gold Project

Argus Metals has entered into an agreement with AK Drilling to implement minimum 2,500 m drill program as part of its totally owned Kaituma uranium and gold project, at north-west Guyana. Drilling will begin before May 2012 end.

In this contract operation, AK Drilling will complete at least 2,500 m of reverse circulation drilling lining up 150m long drill holes over five fences. This is specific for uranium and gold anomalies that were detected through airborne and ground-based exploration work directed by BHP, StrataGold, AREVA (nee Cogema), validated by Company's proprietary ground-based exploration programs in 2010.

The Kaituma Uranium/Gold Project characterizes geophysical or geochemical uranium target included in episyenite intrusive in Guyana Shield Greenstone Belt having analogous deposit-like geological models such as Namibia-based Husab deposit of Extract Resources (319.9M lb U3O8 at 519ppm U3O8). Other model is Brazil-based Lago Real Mine, having resources of 125M lb U3O8 at about 0.25% U3O8. The major Kaituma uranium target extends over 10 km and 1km wide scatters by grades from trace up to 0.23% U in saprolite trenches, and in weathered outcrop from trace up to 0.0948% eU .

The 1982 Cogema soil sampling and geophysical program, followed by BHP airborne radiometric survey in 1996 and StrataGold 2007 stream, soils and trenching program defines the Kaituma East and West PLs stretching up to 10 km strike length of radiometric anomalies.

The Kaituma West PL, (PL29/2011) operation has detected three gold anomalies with grades from trace and up to 827 ppb Au, representing the integration with both hydrothermal alteration in greenstones on intrusive margins and also shear-based mineralization within the intrusive rock.

The Kaituma project was procured from Newmont Overseas Exploration and StrataGold.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Argus Contracts AK Drilling to Initiate Kaituma Uranium/Gold Project. AZoMining. Retrieved on June 12, 2024 from https://www.azomining.com/News.aspx?newsID=6353.

  • MLA

    Scanlon, Joel. "Argus Contracts AK Drilling to Initiate Kaituma Uranium/Gold Project". AZoMining. 12 June 2024. <https://www.azomining.com/News.aspx?newsID=6353>.

  • Chicago

    Scanlon, Joel. "Argus Contracts AK Drilling to Initiate Kaituma Uranium/Gold Project". AZoMining. https://www.azomining.com/News.aspx?newsID=6353. (accessed June 12, 2024).

  • Harvard

    Scanlon, Joel. 2019. Argus Contracts AK Drilling to Initiate Kaituma Uranium/Gold Project. AZoMining, viewed 12 June 2024, https://www.azomining.com/News.aspx?newsID=6353.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.